He joins from Intertek where he was mostly recently responsible for developing Intertek’s business across all of its main service lines in the Middle East and North Africa. During his 14 years at Intertek he established its global chemical and pharmaceuticals division comprising more than 30 expert laboratories and consulting offices in over 20 countries worldwide.
Dawn Marriott-Sims, joint chief operating officer at Capita, said: "Andrew joins us with an outstanding track record of delivering strong growth globally in the life science and related industries. He will help ensure that Capita’s commercial know-how effectively complements Fera’s scientific expertise, developing the scientific capability it can offer existing and new customers. The science services market is one we’ve been excited about for some time and we see the Fera joint venture, and Andrew’s appointment, laying firm foundations for an additional growth market for Capita."
Swift said: "I am excited to be joining Capita so recently after its first, major acquisition in science services. Fera is a first class science business, combining cutting edge research and innovation with horizon scanning, policy and strategy development. It excels in expert identification, measurement and modelling and can help industries produce accurate and compelling risk assessments, mitigation and contingency response across the entire agri-food chain. It has not yet been able to reach its full commercial potential because of obvious limits on investment, recruitment and marketing but this market is rich in opportunity for such an expert solutions provider which Capita is now determined to support. "
Fera employ around 500 people, including more than 300 scientists, at the National Agri-food innovation campus near York.